Long-term bitcoin holders are selling at the fastest pace since August, while some industry observers suggest the market may ...

Even though the Fed's decision to hold interest rates was widely expected, geopolitical tensions and a rotation into haven ...

Gold and other hard assets are rallying on dollar weakness, but bitcoin is lagging as markets continue to treat it as a liquidity-sensitive risk asset.

Crypto markets fell further overnight as bitcoin and ether extended losses, metals tumbled and liquidation pressure hit ...

"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Data at ASH 2025 highlighted that standardized workflows, education, monitoring innovations, and collaboration are steadily ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point for two distinct therapeutic pathways: Hodgkin’s lymphoma (HL) and ...

Genmab plans to present full results at an upcoming medical meeting.

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

Sarah Larson ONCOLOGY Associate Professor Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...